Sep 2026
Blood biomarkers of brain damage in Transient Ischemic Attack: the role of plasma NfL and GFAP
F. Berinato, A. Morotti, Giovanni Baronchelli et al.
· Journal of Neurology · 0 citations
We have 3 of 88 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
Open access
Aug 2026
GLP-1 receptor agonists for Alzheimer’s disease: Lessons from trials and translational challenges
Although GLP-1 receptor agonists show strong mechanistic rationale and supportive epidemiological signals for neuroprotection, large randomized trials in symptomatic AD have yielded negative clinical outcomes and do not support the therapeutic use in AD.
R. Stringhi, Alessandro Padovani, Elena Marcello
· Cell Reports Medicine · 0 citations
Sep 2026
Toward harmonized reporting of Alzheimer’s disease biomarkers in clinical practice
The principles of harmonized reporting for Alzheimer’s disease biomarkers and a structured framework for standardized clinical neurochemistry reports are discussed and a structured framework for standardized clinical neurochemistry reports is proposed.
L. Agnello, Andrea Pilotto, L. Gaetani et al.
· Clinical Chemistry and Labor... · 0 citations